The Use of Biological Feedback in Complex Treatment of Patients with Rheumatoid Arthritis and Systemic Sclerosis
Abstract
There are significant emotional problems in patients with systemic sclerosis (SS) and rheumatoid arthritis (RA), including most expressed symptoms of anxiety and depression that complicate the process of social and psychological adaptation of patients, reduce the level of subjective control as an attribute of personal responsibility for controlling their disease. The effectiveness of the biofeedback (BFB) training in
the treatment of patients with rheumatoid arthritis and systemic sclerosis is analyzed. Analysis of the effectiveness of treatment was conducted by studying the dynamics of a number of psychological indices (the level of subjective control, reactive and personal anxiety, depression) and their comparison in patients of the main and control groups before and after the treatment. Correction of the psycho-emotional state of patients with SS and RA was carried out using biofeedback (BFB), based on the principle of self-regulation of body functions using external feedback systems. There was a significant reduction in anxiety and depressive reactions in patients, during the process of BFB therapy, accompanied by a significant decrease of scores
by Spielberger–Khanin and Beck psychological tests, noted a significant effect of increasing the level of subjective control that can improve the effectiveness of therapy and long-term disease prognosis. Thus, the additional application of BFB training in complex treatment of SS and RA patients promoted the improvement of the efficiency of the treatment and rehabilitation carried out and the improvement of the patients’ quality of life.
Keywords: BFB training, systemic sclerosis, rheumatoid arthritis, rheumatic diseases, reactive anxiety, personality anxiety, depression, level of subjective control
References
[1] Astakhova, A. I., Kicina, T. A., and Izvestiya, Yu. Fu. (2008). BOS trening kak instrument terapevticheskogo kontakta. Tekhnicheskie nauki, vol. 6, no. 83, S. 49–53.
[2] Guseva, N. G. (2008). Sistemnaya sklerodermiya, in E. L. Nasonova and V. A.Nasonovoj (eds.) Revmatologiya. Nacional‘noe rukovodstvo, S. 447–466. M.: GEOTAR-Media.
[3] Chuprikova, E. G., Chuprikov, A. P., and Izvestiya, T. R. T. U. (2000). Diagnosticheskie i terapevticheskie vozmozhnosti EEG-BOS-treninga v psixoterapii, vol. 4, no. 18, S. 31–33.
[4] Nasonov, E. L. (2008). Vnedrenie vysokikh medicinskikh tekhnologij v revmatologii:problemy i resheniya. Nauchno-prakticheskaya revmatologiya, vol. 2, S. 4–5.
[5] Nasonov, E. L. 2010. Racional‘naya terapiya revmatoidnogo artrita, S. 224. M: Miklosh.
[6] Ply‘kin, A. N. (2016). Obuchayushhaya metodika BOS-trening kak nauchit‘sya protivostoyat‘ stressu. Simvol nauki, vol. 4–4, no. 16, S. 176–182.
[7] Pizova, N. V., Spirin, N. N., and Rukavishnikov, A. A. (2003). Osobennosti lichnosti bol‘nykh s sistemnymi revmaticheskimi zabolevaniyami. Zh. nevrologii i psikhiatrii im. S.S.Korsakova, vol. 103, no. 12, S. 47–48.
[8] Biryukova, E. V. and Mosolov, S. N. (2011). Prognoz effektivnosti nejrofidbeka u bol‘nykh trevozhnymi rasstrojstvami, rezistentnymi k psikhofarmakoterapii. Social‘naya i klinicheskaya psixiatriya, T. 21, no. 2, S. 75–81.
[9] Aslanyan, E. V., Kiroj, V. N., Lazurenko, D. M., et al. (2013). Svojstva nervnykh processov i effektivnost‘ BOS-treninga. Psikhologicheskij zhurnal, T. 34, no. 2, S. 108– 116.
[10] Smetankin, A. A. (2002). Zdorov‘e bez lekarstv. Biologicheskaya obratnaya svyaz‘. Zdorov‘e Rossii i biologicheskaya obratnaya svyaz‘, vol. 2, S. 10–37.
[11] Schegol‘kov, A. M., Dybov, M. D., Budko, A. A., et al. (2008). Sovremennye metody bioupravleniya v medicinskoj reabilitacii bol‘nykh s psikhosomaticheskoj patologiej. Vestnik vosstanovitel‘noj mediciny, vol. 3, S. 13–16.
[12] Folomeeva, O. M., Nasonov, E. L., Andrianova, I. A. (2010). i dr. Revmatoidnyj artrit v revmatologicheskoj praktike Rossii: tyazhest‘ zabolevaniya v rossijskoj populyacii bol‘nykh. Odnomomentnoe (poperechnoe) epidemiologicheskoe issledovanie (RAISER). Nauchno-prakticheskaya revmatologiya, vol. 1, S. 50–61.
[13] Folomeeva, O. M. and E‘rdes, Sh. F. (2007). Rasprostranennost‘ i social‘naya znachimost‘ revmaticheskikh zabolevanij v Rossijskoj Federacii. Doktor (revmatologiya), S.10–12.
[14] Chichasova, N. V., Kanevskaya, M. Z., and Imametdinova, G. R. (2010). i dr. Otdalennye iskhody revmatoidnogo artrita v zavisimosti ot srokov nachala terapii bazisnymi protivovospalitel‘nymi preparatami. Nauchno-prakticheskaya revmatologiya, vol. 3, S. 23–30.
[15] Karelin, A. (2007). Bol‘shaya enciklopediya psikhologicheskikh testov, s. 416. M.: Eksmo.
[16] Ellis, R. M., Moitra, R., and North, N. (August 2005). Turgenev’s ”living relic”: an early description of scleroderma? Journal of the Royal Society of Medicine, vol. 98, no. 8, pp. 372–374.
[17] Hyphantis, T. N., Tsifetaki, N., Pappa, C., et al. ( January 2007). Clinical features and personality traits associated with psychological distress in systemic sclerosis patients. Journal of Psychosomatic Research, vol. 62, no. 1, pp. 47–56.
[18] Hyphantis, T. N., Tsifetaki, N., Siafaka, V., et al. (October 2007). The impact of psychological functioning upon systemic sclerosis patients’ quality of life. Seminars in Arthritis and Rheumatism, vol. 37, no. 2, pp. 81–92.
[19] Suarez-Almazor, M. E., Kallen, M. A., Roundtree, A. K. et al. (August 2007). Disease and symptom burden in systemic sclerosis: A patient perspective. The Journal of Rheumatology, vol. 34, no. 8, pp. 1718–1726.